IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8987250 B1

PDFFull Text
Date of Patent:
Mar. 24, 2015

Filed:

Apr. 19, 2013

Therapeutic compounds

Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Kerim Babaoglu, Lansdale, PA (US);

Gediminas Brizgys, San Mateo, CA (US);

Jake Cha, Burlingame, CA (US);

Xiaowu Chen, Hillsborough, CA (US);

Hongyan Guo, San Mateo, CA (US);

Randall L. Halcomb, Foster City, CA (US);

Xiaochun Han, San Mateo, CA (US);

Richard Huang, San Mateo, CA (US);

Hongtao Liu, Cupertino, CA (US);

Ryan McFadden, Foster City, CA (US);

Michael L. Mitchell, Hayward, CA (US);

Yingmei Qi, Sunnyvale, CA (US);

Paul A. Roethle, San Francisco, CA (US);

Lianhong Xu, Palo Alto, CA (US);

Hong Yang, Fremont, CA (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:

Gilead Sciences, Inc.

Primary Examiner:

Wu-Cheng Winston Shen

Assistant Examiner:

Jean Cornet

Int. Cl.
CPC ...
A01N 43/00 (2006.01); A61K 31/00 (2006.01); C07D 417/14 (2006.01); C07D 417/10 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/506 (2006.01); A61K 31/496 (2006.01); A61K 31/428 (2006.01); C07D 471/04 (2006.01); A61K 31/437 (2006.01); A61K 31/513 (2006.01); A61K 31/497 (2006.01); A61K 31/5377 (2006.01); A61K 31/454 (2006.01); C07D 498/04 (2006.01); A61K 31/5383 (2006.01); A61K 31/4375 (2006.01); A61K 31/4709 (2006.01); A61K 31/501 (2006.01); C07D 487/04 (2006.01); A61K 31/4985 (2006.01); A61K 31/553 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01); A61K 31/4741 (2006.01); C07D 277/82 (2006.01); C07D 491/06 (2006.01); C07D 417/04 (2006.01); C07D 277/66 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); C07D 417/10 (2013.01); A61K 31/4439 (2013.01); A61K 31/444 (2013.01); A61K 31/506 (2013.01); A61K 31/496 (2013.01); A61K 31/428 (2013.01); C07D 471/04 (2013.01); A61K 31/437 (2013.01); A61K 31/513 (2013.01); A61K 31/497 (2013.01); A61K 31/5377 (2013.01); A61K 31/454 (2013.01); C07D 498/04 (2013.01); A61K 31/5383 (2013.01); A61K 31/4375 (2013.01); A61K 31/4709 (2013.01); A61K 31/501 (2013.01); C07D 487/04 (2013.01); A61K 31/4985 (2013.01); A61K 31/553 (2013.01); A61K 31/551 (2013.01); A61K 45/06 (2013.01); A61K 31/4741 (2013.01); C07D 277/82 (2013.01); C07D 491/06 (2013.01); C07D 417/04 (2013.01); C07D 277/66 (2013.01);
Abstract

Compounds disclosed herein including compounds of formula I': and salts thereof are provided. Pharmaceutical compositions comprising compounds disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection using compounds disclosed herein are also provided.

Find Patent Forward Citations

Loading…